Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
41 hedge funds and large institutions have $23.5M invested in Histogen Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 7 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
182% more capital invested
Capital invested by funds: $8.31M → $23.5M (+$15.2M)
78% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 9
24% more call options, than puts
Call options by funds: $1.19M | Put options by funds: $958K
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
3% more funds holding
Funds holding: 40 → 41 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$2.16M |
| 2 |
Renaissance Technologies
New York
|
+$275K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$187K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$115K |
| 5 |
JRP
Jasper Ridge Partners
Menlo Park,
California
|
+$108K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Axa
Paris,
France
|
-$1.38M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$389K |
| 3 |
PC
Polar Capital
London,
United Kingdom
|
-$311K |
| 4 |
D.E. Shaw & Co
New York
|
-$175K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$78K |
HSTO Hedge Fund Activity: Q4 2016 in Review
41 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q4 2016, worth a combined $23.5M — up 182% from $8.31M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new HSTO positions and 7 closed out — a net gain of 1 holder — while 16 added to existing stakes and 9 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $2.16M. The largest seller was Axa, cutting an estimated $1.38M.
- 41 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q4 2016, up from 40 in Q3 2016.
- Funds reported $23.5M of Histogen Inc. Common Stock stock for Q4 2016, up 182% quarter-over-quarter.
- 8 funds opened new Histogen Inc. Common Stock positions in Q4 2016 and 7 closed out, a net change of +1 holder.
- The largest Histogen Inc. Common Stock buyer in Q4 2016 was Millennium Management, an estimated $2.16M added.
- The largest Histogen Inc. Common Stock seller in Q4 2016 was Axa, an estimated $1.38M sold.
Based on aggregated 13F filings for Q4 2016.